NEPHROS Business Summary

Nephros Inc. (NEPH) is a commercial-stage medical technology company that generates revenue primarily through the sale of high-performance water filtration and pathogen detection solutions. The company operates through two core business segments: Water Filtration, which provides FDA-cleared ultrafilters to hospitals for infection control (retaining bacteria like Legionella and Pseudomonas) and to commercial clients for water quality enhancement; and Renal Products, managed via its Specialty Renal Products subsidiary, which focuses on advanced hemodiafiltration therapies for end-stage renal disease. Nephros employs a "razor-and-blade" business model, driving recurring "programmatic" revenue from replaceable filter cartridges alongside emergency response sales and emerging service-based offerings. In a competitive landscape dominated by diversified giants such as Pentair plc, 3M Company, and Fresenius Medical Care, Nephros distinguishes itself as a specialized, high-density filtration leader, maintaining a "gold standard" niche in medical-grade point-of-use and point-of-entry water safety. Founded in 1997, Nephros is currently led by President and CEO Robert Banks, a mechanical engineer with an MBA from the University of Maryland who took the helm in May 2023 to transition the company toward sustained profitability. The executive team includes CFO Judy Krandel, a Wharton and Chicago Booth alumna with over 20 years of experience in asset management and financial leadership, and Michael Milman, VP of R&D and Manufacturing, who oversees the company’s technical innovation pipeline. The company’s strategic direction is governed by a board that includes Arthur Amron of Wexford Capital and independent directors such as Joe Harris and Lisa Nettis. Nephros is backed by notable institutional investors, with Wexford Capital LP maintaining a significant ownership stake, alongside Topline Capital Management and Vanguard Group, reflecting a stable capital structure as the company expands into new markets like PFAS filtration and regional territories such as Puerto Rico.